Dry AMD Symposium 1

Related

• 

  Pegcetacoplan vs Avacincaptad Pegol in Patients With Geographic Atrophy: An Anchored Matching-Adjusted Indirect Comparison of the Phase 3 Trials

  Paul Hahn, MD, PhD, FASRS

  Annual Meeting Talks

  2023

• 

  First Time Results of VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy

  Omer Trivizki, MD, MBA

  Updates from the Field

  2025

• 

  Early Progression of Atrophy in AMD: Post Hoc Analysis From the GATHER1 Study

  David R Lally, MD

  Annual Meeting Talks

  2022